Saving Medicare with rapamycin(?)

How to save Medicare: the anti-aging remedy

Mikhail V. Blagosklonny
Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA

The unprecedented progress in aging research has revealed that rapamycin, a clinically approved drug, is actually an anti-aging agent, which potentially could be employed to delay age-related diseases, thus extending healthy life span. The possibility of preventing diseases by staying young is remarkable in itself. At the same time this advance could save Medicare as we know it. Here I discuss how anti-aging interventions could solve otherwise intractable political problems without tax increases or curtailment of health care benefits.


Leave a Comment:

1 comment
Anonymous says September 27, 2012

Given the state of the economy and the lack of savings of those nearing retirement age, are you sure you want everyone to live longer?

Just kidding!

Add Your Reply